SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-014234
Filing Date
2018-03-13
Accepted
2018-03-13 07:01:17
Documents
68
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F tv487506_20f.htm 20-F 1658018
2 EXHIBIT 4.6 tv487506_ex4-6.htm EX-4.6 33130
3 EXHIBIT 8.1 tv487506_ex8-1.htm EX-8.1 3219
4 EXHIBIT 12.1 tv487506_ex12-1.htm EX-12.1 8528
5 EXHIBIT 12.2 tv487506_ex12-2.htm EX-12.2 8436
6 EXHIBIT 13.1 tv487506_ex13-1.htm EX-13.1 5541
7 EXHIBIT 15.1 tv487506_ex15-1.htm EX-15.1 2800
8 GRAPHIC tv487506_img3.jpg GRAPHIC 68345
9 GRAPHIC tv487506_img4.jpg GRAPHIC 39420
10 GRAPHIC tv487506_img5.jpg GRAPHIC 29007
11 GRAPHIC tv487506_img1.jpg GRAPHIC 9389
12 GRAPHIC tv487506_img2.jpg GRAPHIC 37673
  Complete submission text file 0001144204-18-014234.txt   5007156

Data Files

Seq Description Document Type Size
13 XBRL INSTANCE DOCUMENT glmd-20171231.xml EX-101.INS 697319
14 XBRL TAXONOMY EXTENSION SCHEMA glmd-20171231.xsd EX-101.SCH 34397
15 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE glmd-20171231_cal.xml EX-101.CAL 41084
16 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE glmd-20171231_def.xml EX-101.DEF 210295
17 XBRL TAXONOMY EXTENSION LABEL LINKBASE glmd-20171231_lab.xml EX-101.LAB 269523
18 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE glmd-20171231_pre.xml EX-101.PRE 255571
Mailing Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317
Business Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317 97236938448
Galmed Pharmaceuticals Ltd. (Filer) CIK: 0001595353 (see all company filings)

IRS No.: 981147233 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36345 | Film No.: 18685211
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1